Dr. Rothman is the primary investigator on the Clinical
Utility of Preemptive Surge Measures Enacted as a Result of
Conventional and Internet-Based Influenza Surveillance project,
also known as the "Google Flu" project.
For the PACER program Dr. Rothman's team has focused on
evaluation of the utility of surveillance for guiding health system
planning and response. Work in the first phase of the program
included national surveys with health departments and focus groups
with local state, and federal representatives. Current studies
evaluate novel surveillance systems (particularly Google Flu
Trends) for their reliability and utility at the local level.
Research includes primary data analysis and convening of expert
consensus meetings. Dr. Rothman and team's findings have been
published in Clinical Infectious Diseases and highlighted by
multiple new organizations, including NPR.
Dr. Rothman oversees a translational research program focusing
on infectious diseases in acute care settings, with studies in
epidemiology, diagnostic test development and implementation, and
the public health implications of infectious diseases from an
emergency care perspective. His studies are translational and
cross-cutting. Work has been published in leading journals in the
field including Lancet ID, JID, J Clin Micro, Annals of Emergency
Medicine and Academic Emergency Medicine.
Dr. Rothman is the Research Director for the Johns Hopkins
Department of Emergency Medicine, and Professor of Emergency
Medicine at Johns Hopkins University. In addition to his role
in the PACER program, Dr. Rothman is also the diagnostics lead for
the MidAltantic Regional Center for Excellence in Emerging and
Biothreat Diseases and CoI on several NIAID projects involving
diagnosis and evaluation of infectious diseases in emergency
settings. He is also a member of the CDC Emerg ID Net Study
Dr. Rothman's other research interests include: Molecular
Diagnostic Test Development, Rapid Detection of Emerging Infection;
Infectious Disease Surveillance; Clinical Decision Guidelines; HIV
testing and HIV-related illnesses.